A5074633327- Diabetes Management and Research
- Cystic Fibrosis Research Advances
- Child Nutrition and Feeding Issues
- Parathyroid Disorders and Treatments
- Congenital Ear and Nasal Anomalies
- Diabetes and associated disorders
- Pancreatic function and diabetes
- Bone health and treatments
- Diet and metabolism studies
- Heterotopic Ossification and Related Conditions
- Medical Imaging and Pathology Studies
- Ion Transport and Channel Regulation
- Genetic Syndromes and Imprinting
- Pharmacological Effects and Toxicity Studies
- Electrolyte and hormonal disorders
Baystate Medical Center
2024
Children's Hospital & Medical Center
2019-2023
University of Nebraska Medical Center
2023
Rhode Island Hospital
2017
Brown University
2017
Yale University
2015
Diabetes mellitus type 1 (DM1) and 2 (DM2) are well-established risk factors for cardiovascular disease but differ pathophysiologically in that DM1 results from insulin deficiency, whereas DM2 insensitivity. The association between events remains undetermined. For or patients aged 46 to 75 years receiving care at outpatient facilities with primary and/or endocrinology enrolled the National Cardiovascular Data Registry Veradigm Metabolic 2017-2022, we compared prevalence of incident including...
Familial hypocalciuric hypercalcemia (FHH) is typically a benign condition characterized by elevated serum calcium, low urinary calcium excretion, and non-suppressed circulating levels of parathyroid hormone (PTH), usually requiring no intervention. FHH inherited in an autosomal-dominant manner. Three subtypes are described, representing variants genes with critical roles extracellular calcium-sensing. FHH1, due to heterozygous inactivating the calcium-sensing receptor gene (CASR) accounts...
Summary Multiple research studies address the anti-insulinemic effect of growth hormone (GH). We report a case patient with anterior hypopituitarism on GH replacement who later developed type 1 diabetes mellitus (T1DM). Recombinant human (rhGH) therapy was discontinued at time completion. Because significantly improved glycemic control, this weaned off subcutaneous insulin. He regressed from stage 3 to 2 T1DM and remained in status for least years until writing paper. The diagnosis...